Li et al., 2019 - ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor. Nature medicine   25(7):1116-1122 Full text @ Nat. Med.
2 Genes / Markers
Marker Type Symbol Name
Gene mrc1a mannose receptor, C type 1a
Gene raf1a Raf-1 proto-oncogene, serine/threonine kinase a
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.